13F Holdings
中文EN

OPRX OptimizeRx Corp

Services-Business Services, NEC · Nasdaq · SEC CIK 1448431 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-14.0%
TTM net income YoY14,655.9%
TTM EPS YoY2,500.0%
Revenue 3-yr CAGR14.5%
Net income 3-yr CAGR—

Margins

Gross margin75.3%
Operating margin12.3%
Net margin5.3%
FCF margin21.1%
EBITDA margin16.8%

Returns

ROE3.9%
ROA3.0%
ROIC (approx.)5.5%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets17.4%
Debt / equity0.10x
Current ratio5.06x
Interest coverage3.12x

Cash quality & payout

Operating cash flow / net income3.98x
Accruals ratio-9.0%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$109.43M$92.13M$71.52M$62.45M$61.29M
Cost of revenue$35.83M$32.75M$28.62M$23.48M$25.65M
Gross profit$73.59M$59.38M$42.90M$38.97M$35.64M
R&D expense$0$0———
SG&A expense———$33.49M$27.70M
Operating income$11.69M-$13.71M-$26.40M-$12.29M$361,100
Interest expense$5.29M$6.16M$1.45M——
Pretax income$6.95M-$19.39M-$25.16M-$11.44M$378,079
Income tax$1.82M$725,000-$7.60M——
Net income$5.13M-$20.11M-$17.57M-$11.44M$378,079
EBITDA$16.02M-$9.38M-$24.00M-$10.27M$2.33M
EPS (basic)0.28-1.10-1.03-0.640.02
EPS (diluted)0.27-1.10-1.03-0.640.02
Weighted avg. shares (diluted)19.00M18.29M17.12M17.78M17.69M
Balance sheet
Cash & equivalents$23.36M$13.38M$13.85M$18.21M$84.68M
Short-term investments$0$0—$55.93M—
Receivables$37.75M$38.21M$36.25M$22.16M$24.80M
Current assets$64.72M$53.97M$54.33M$98.58M$115.11M
PP&E, net$106,000$150,000$149,000$137,448$143,818
Goodwill$70.87M$70.87M$78.36M$22.67M$14.74M
Intangibles$40.80M$45.52M$6.18M$13.02M$10.65M
Total assets$176.92M$171.17M$183.37M$134.65M$140.99M
Current liabilities$21.26M$18.65M$17.88M$8.40M$9.37M
Short-term debt$4.25M$2.00M$2.00M——
Long-term debt$21.42M$30.82M$34.23M——
Total debt$25.68M$32.82M$36.23M——
Total liabilities$48.62M$54.17M$56.82M$8.54M$9.61M
Shareholders' equity$128.29M$117.00M$126.55M$126.11M$131.38M
Net debt$2.31M$19.44M$22.38M——
Shares outstanding18.76M18.45M18.16M18.29M17.86M
Cash flow statement
Operating cash flow$18.71M$4.89M-$7.24M$10.65M$726,039
Capital expenditure$58,000$112,000$87,000$81,005$100,322
Free cash flow$18.66M$4.78M-$7.33M$10.57M$625,717
Investing cash flow$68,000-$450,000-$25.34M-$58.18M-$485,999
Financing cash flow-$8.80M-$4.91M$28.22M-$18.95M$73.92M
Depreciation & amortization$4.33M$4.33M$2.40M$2.02M$1.97M
Stock-based compensation$6.96M$11.47M$13.72M$15.75M$5.49M
Share buybacks——$7.52M$20.02M—

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.